Central, China

Haiyun Bai

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Haiyun Bai

Introduction: Haiyun Bai is a notable inventor based in Central, China. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on aromatic heterocyclic compounds. Her research focuses on developing compounds with therapeutic potential, showcasing her commitment to advancing medical science.

Latest Patents: Haiyun Bai holds a patent for an aromatic heterocyclic compound, pharmaceutical composition, and its use. The patent specifically discloses a compound represented by formula I, along with its stereoisomers, diastereomers, and pharmaceutically acceptable salts. This compound exhibits a novel structure, demonstrating good CDK7 inhibitory activity and selectivity, which could have important implications for drug development.

Career Highlights: Throughout her career, Haiyun Bai has been associated with Recursion Pharmaceuticals, Inc., where she has contributed to various research initiatives. Her work has been instrumental in exploring new therapeutic avenues and enhancing the understanding of complex biological systems.

Collaborations: Some of her notable coworkers include Jérémy Besnard and Xiaohui Gu, who have collaborated with her on various projects, further enriching the research environment at Recursion Pharmaceuticals.

Conclusion: Haiyun Bai's innovative contributions to the field of pharmaceuticals, particularly through her patented work on aromatic heterocyclic compounds, highlight her role as a leading inventor in her domain. Her ongoing research continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…